|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2006-3-6
|
|
pubmed:abstractText |
Efficient gene transfer to bone marrow derived mesenchymal stem cells (MSC) would provide an important opportunity to express potent anticancer agents in the tumour microenvironment because of their contribution to the tumour stroma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1099-498X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
253-64
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:16288493-Animals,
pubmed-meshheading:16288493-Bone Marrow Cells,
pubmed-meshheading:16288493-Burkitt Lymphoma,
pubmed-meshheading:16288493-Disease Models, Animal,
pubmed-meshheading:16288493-Gene Transfer Techniques,
pubmed-meshheading:16288493-Genetic Vectors,
pubmed-meshheading:16288493-HIV,
pubmed-meshheading:16288493-Humans,
pubmed-meshheading:16288493-Lentivirus,
pubmed-meshheading:16288493-Mesenchymal Stem Cell Transplantation,
pubmed-meshheading:16288493-Mice,
pubmed-meshheading:16288493-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:16288493-Transduction, Genetic,
pubmed-meshheading:16288493-Transgenes,
pubmed-meshheading:16288493-Vascular Endothelial Growth Factor Receptor-2,
pubmed-meshheading:16288493-Viral Envelope Proteins
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model.
|
|
pubmed:affiliation |
Department of Haematology, University College London, London, UK.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
